nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclothiazide—CA1—nerve—Parkinson's disease	0.0808	0.0973	CbGeAlD
Cyclothiazide—CA4—nerve—Parkinson's disease	0.0631	0.076	CbGeAlD
Cyclothiazide—CA4—hindbrain—Parkinson's disease	0.0473	0.0569	CbGeAlD
Cyclothiazide—FXYD2—head—Parkinson's disease	0.0466	0.0561	CbGeAlD
Cyclothiazide—CA2—hindbrain—Parkinson's disease	0.0392	0.0472	CbGeAlD
Cyclothiazide—CA1—forebrain—Parkinson's disease	0.0335	0.0403	CbGeAlD
Cyclothiazide—FXYD2—Ion transport by P-type ATPases—ATP1A3—Parkinson's disease	0.0322	0.19	CbGpPWpGaD
Cyclothiazide—CA1—cardiovascular system—Parkinson's disease	0.0283	0.0341	CbGeAlD
Cyclothiazide—CA4—brainstem—Parkinson's disease	0.0271	0.0326	CbGeAlD
Cyclothiazide—CA4—forebrain—Parkinson's disease	0.0262	0.0315	CbGeAlD
Cyclothiazide—CA2—embryo—Parkinson's disease	0.0245	0.0295	CbGeAlD
Cyclothiazide—CA2—brainstem—Parkinson's disease	0.0225	0.0271	CbGeAlD
Cyclothiazide—CA4—cardiovascular system—Parkinson's disease	0.0221	0.0266	CbGeAlD
Cyclothiazide—CA2—forebrain—Parkinson's disease	0.0217	0.0261	CbGeAlD
Cyclothiazide—CA1—spinal cord—Parkinson's disease	0.0216	0.026	CbGeAlD
Cyclothiazide—SLC22A6—brain—Parkinson's disease	0.0196	0.0236	CbGeAlD
Cyclothiazide—CA1—head—Parkinson's disease	0.0192	0.0231	CbGeAlD
Cyclothiazide—CA4—medulla oblongata—Parkinson's disease	0.0189	0.0228	CbGeAlD
Cyclothiazide—CA2—cardiovascular system—Parkinson's disease	0.0183	0.0221	CbGeAlD
Cyclothiazide—CA1—nervous system—Parkinson's disease	0.0182	0.0219	CbGeAlD
Cyclothiazide—CA1—central nervous system—Parkinson's disease	0.0175	0.0211	CbGeAlD
Cyclothiazide—CA4—midbrain—Parkinson's disease	0.0173	0.0208	CbGeAlD
Cyclothiazide—CA4—spinal cord—Parkinson's disease	0.0168	0.0203	CbGeAlD
Cyclothiazide—CA2—medulla oblongata—Parkinson's disease	0.0157	0.0189	CbGeAlD
Cyclothiazide—CA4—head—Parkinson's disease	0.015	0.018	CbGeAlD
Cyclothiazide—CA2—midbrain—Parkinson's disease	0.0143	0.0172	CbGeAlD
Cyclothiazide—CA4—nervous system—Parkinson's disease	0.0142	0.0171	CbGeAlD
Cyclothiazide—CA2—spinal cord—Parkinson's disease	0.014	0.0168	CbGeAlD
Cyclothiazide—CA1—brain—Parkinson's disease	0.0139	0.0167	CbGeAlD
Cyclothiazide—CA4—central nervous system—Parkinson's disease	0.0137	0.0165	CbGeAlD
Cyclothiazide—CA4—cerebellum—Parkinson's disease	0.0134	0.0161	CbGeAlD
Cyclothiazide—CA2—head—Parkinson's disease	0.0124	0.015	CbGeAlD
Cyclothiazide—CA2—nervous system—Parkinson's disease	0.0118	0.0142	CbGeAlD
Cyclothiazide—CA2—central nervous system—Parkinson's disease	0.0113	0.0136	CbGeAlD
Cyclothiazide—FXYD2—Ion channel transport—ATP1A3—Parkinson's disease	0.0112	0.0658	CbGpPWpGaD
Cyclothiazide—FXYD2—Ion channel transport—TRPM7—Parkinson's disease	0.0112	0.0658	CbGpPWpGaD
Cyclothiazide—CA2—cerebellum—Parkinson's disease	0.0111	0.0133	CbGeAlD
Cyclothiazide—FXYD2—Calcium Regulation in the Cardiac Cell—GRK6—Parkinson's disease	0.0109	0.0643	CbGpPWpGaD
Cyclothiazide—CA4—brain—Parkinson's disease	0.0109	0.0131	CbGeAlD
Cyclothiazide—FXYD2—Calcium Regulation in the Cardiac Cell—GRK5—Parkinson's disease	0.00904	0.0533	CbGpPWpGaD
Cyclothiazide—CA2—brain—Parkinson's disease	0.009	0.0108	CbGeAlD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00388	0.0229	CbGpPWpGaD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00388	0.0229	CbGpPWpGaD
Cyclothiazide—CA1—C-MYB transcription factor network—HSPA8—Parkinson's disease	0.00349	0.0206	CbGpPWpGaD
Cyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00246	0.0145	CbGpPWpGaD
Cyclothiazide—CA1—C-MYB transcription factor network—GSTM1—Parkinson's disease	0.00245	0.0145	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00235	0.0139	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00235	0.0139	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00226	0.0133	CbGpPWpGaD
Cyclothiazide—SLC12A3—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00226	0.0133	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00208	0.0123	CbGpPWpGaD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00206	0.0121	CbGpPWpGaD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.0019	0.0112	CbGpPWpGaD
Cyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00161	0.0095	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00148	0.00874	CbGpPWpGaD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00135	0.00796	CbGpPWpGaD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.0013	0.00765	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00125	0.00736	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00115	0.00677	CbGpPWpGaD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00113	0.00665	CbGpPWpGaD
Cyclothiazide—FXYD2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00108	0.00638	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—MCCC1—Parkinson's disease	0.00107	0.00629	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—ND3—Parkinson's disease	0.00107	0.00629	CbGpPWpGaD
Cyclothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00103	0.00606	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—ND3—Parkinson's disease	0.00102	0.00603	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—MCCC1—Parkinson's disease	0.00102	0.00603	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—TALDO1—Parkinson's disease	0.001	0.00591	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—OMD—Parkinson's disease	0.001	0.00591	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000984	0.0058	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000984	0.0058	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—ND3—Parkinson's disease	0.00098	0.00578	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—MCCC1—Parkinson's disease	0.00098	0.00578	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—TALDO1—Parkinson's disease	0.000962	0.00567	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—OMD—Parkinson's disease	0.000962	0.00567	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—NDUFB11—Parkinson's disease	0.000951	0.0056	CbGpPWpGaD
Cyclothiazide—SLC22A6—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000946	0.00557	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—OMD—Parkinson's disease	0.000922	0.00543	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—TALDO1—Parkinson's disease	0.000922	0.00543	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—NDUFB11—Parkinson's disease	0.000912	0.00537	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—GCH1—Parkinson's disease	0.000907	0.00535	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—NDUFB11—Parkinson's disease	0.000874	0.00515	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—GCH1—Parkinson's disease	0.00087	0.00513	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—GCH1—Parkinson's disease	0.000834	0.00491	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000819	0.00483	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—GBA—Parkinson's disease	0.000808	0.00476	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—FBP1—Parkinson's disease	0.000808	0.00476	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—DBH—Parkinson's disease	0.000808	0.00476	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000786	0.00463	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—FBP1—Parkinson's disease	0.000775	0.00457	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—DBH—Parkinson's disease	0.000775	0.00457	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—GBA—Parkinson's disease	0.000775	0.00457	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—FBP1—Parkinson's disease	0.000743	0.00438	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—DBH—Parkinson's disease	0.000743	0.00438	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—GBA—Parkinson's disease	0.000743	0.00438	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000683	0.00403	CbGpPWpGaD
Cyclothiazide—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000674	0.00397	CbGpPWpGaD
Cyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000656	0.00387	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—DDC—Parkinson's disease	0.000593	0.0035	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—DDC—Parkinson's disease	0.000569	0.00335	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—GSTA4—Parkinson's disease	0.00056	0.0033	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—DDC—Parkinson's disease	0.000545	0.00321	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—GSTA4—Parkinson's disease	0.000537	0.00317	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000522	0.00308	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—GSTA4—Parkinson's disease	0.000515	0.00304	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—PLA2G6—Parkinson's disease	0.000505	0.00297	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—MAOB—Parkinson's disease	0.000499	0.00294	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—PLA2G6—Parkinson's disease	0.000484	0.00285	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000481	0.00283	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—MAOB—Parkinson's disease	0.000479	0.00282	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—PLA2G6—Parkinson's disease	0.000464	0.00273	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—MAOB—Parkinson's disease	0.000459	0.00271	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—CYP2D6—Parkinson's disease	0.000371	0.00219	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—CTGF—Parkinson's disease	0.000364	0.00215	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—CYP2D6—Parkinson's disease	0.000356	0.0021	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—CTGF—Parkinson's disease	0.000349	0.00206	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000342	0.00202	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—CYP2D6—Parkinson's disease	0.000341	0.00201	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—CYP2E1—Parkinson's disease	0.000339	0.002	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—NQO1—Parkinson's disease	0.000336	0.00198	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—CTGF—Parkinson's disease	0.000335	0.00197	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—TH—Parkinson's disease	0.000331	0.00195	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000329	0.00194	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—CYP2E1—Parkinson's disease	0.000325	0.00192	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—NQO1—Parkinson's disease	0.000322	0.0019	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—CYCS—Parkinson's disease	0.000318	0.00187	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—TH—Parkinson's disease	0.000317	0.00187	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—CYP2E1—Parkinson's disease	0.000312	0.00184	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—NQO1—Parkinson's disease	0.000309	0.00182	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—CYCS—Parkinson's disease	0.000305	0.00179	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—TH—Parkinson's disease	0.000304	0.00179	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—CYCS—Parkinson's disease	0.000292	0.00172	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000286	0.00168	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—COMT—Parkinson's disease	0.000281	0.00166	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—GSTP1—Parkinson's disease	0.00028	0.00165	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—MAOA—Parkinson's disease	0.000279	0.00165	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—HMOX1—Parkinson's disease	0.000276	0.00163	CbGpPWpGaD
Cyclothiazide—SLC22A6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000274	0.00162	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—COMT—Parkinson's disease	0.00027	0.00159	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—GSTP1—Parkinson's disease	0.000268	0.00158	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—MAOA—Parkinson's disease	0.000268	0.00158	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—ABCB1—Parkinson's disease	0.000265	0.00156	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—HMOX1—Parkinson's disease	0.000265	0.00156	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—COMT—Parkinson's disease	0.000259	0.00152	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—GSTP1—Parkinson's disease	0.000257	0.00152	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—GSTM1—Parkinson's disease	0.000257	0.00152	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—MAOA—Parkinson's disease	0.000257	0.00151	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—ABCB1—Parkinson's disease	0.000254	0.0015	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—HMOX1—Parkinson's disease	0.000254	0.0015	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—GSTM1—Parkinson's disease	0.000247	0.00145	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—GPX1—Parkinson's disease	0.000246	0.00145	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—ABCB1—Parkinson's disease	0.000244	0.00144	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—GSTM1—Parkinson's disease	0.000236	0.00139	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—GPX1—Parkinson's disease	0.000236	0.00139	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—MTHFR—Parkinson's disease	0.000227	0.00134	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—GPX1—Parkinson's disease	0.000226	0.00133	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—MTHFR—Parkinson's disease	0.000218	0.00128	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—APOE—Parkinson's disease	0.000212	0.00125	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—MTHFR—Parkinson's disease	0.000209	0.00123	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—APOE—Parkinson's disease	0.000203	0.0012	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—APOE—Parkinson's disease	0.000195	0.00115	CbGpPWpGaD
Cyclothiazide—CA4—Metabolism—INS—Parkinson's disease	0.000181	0.00107	CbGpPWpGaD
Cyclothiazide—CA2—Metabolism—INS—Parkinson's disease	0.000173	0.00102	CbGpPWpGaD
Cyclothiazide—CA1—Metabolism—INS—Parkinson's disease	0.000166	0.00098	CbGpPWpGaD
